Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.415.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.243.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.566NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.480NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.579NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.11 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.435NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.445NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.124NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.569NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.524NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.596.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.473NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.76.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.310NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.185NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.329NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.229NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.342NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.90NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.169NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.528NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.175NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.483NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.181NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.113NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.594NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.328NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.145NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.547NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.247NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.205NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.434NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used